U-Neuron Biomedical

U-Neuron Biomedical EBITDA per Share

The EBITDA per Share of U-Neuron Biomedical (6973.TWO) as of Oct 16, 2026 is -2.01 TWD. In the previous year, EBITDA per Share was -3.34 TWD — a change of -39.86% (higher).

EBITDA per Share

-2.01TWD

YoY

-39.86%

Last updated:

EBITDA per Share of U-Neuron Biomedical is 2024 -2.01 TWD. EBITDA per Share of U-Neuron Biomedical was 2023 -3.34 TWD. It decreases by -39.86% higher compared to the previous year.

The U-Neuron Biomedical EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
-0.47 TWD
Jan 1, 2022
-1.43 TWD
Jan 1, 2023
-3.34 TWD
Jan 1, 2024
-2.01 TWD
The U-Neuron Biomedical EBITDA per Share history
YEAREBITDA per ShareYoY
-2.01TWD-39.86%
-3.34TWD+132.55%
-1.43TWD+204.05%
-0.47TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical Inc, headquartered in Taipei, Taiwan, operates in the Health Care sector within the Biotechnology industry. The company, listed on 20 July 2023, develops cosmetics, health care consumer products, and new drugs. Its drug development focuses on allogeneic amniotic fluid stem cells for applications like erectile dysfunction (UA002) and dry eye (UB003). Cosmetic products, featuring deer amniotic fluid stem cell derivatives, include anti-aging masks, essences, and creams for repair and hydration, primarily sold domestically in Taiwan. U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

EBITDA per Share of U-Neuron Biomedical is -2.01 TWD in 2024.

EBITDA per Share of U-Neuron Biomedical changed from -3.34 TWD to -2.01 TWD, representing a -39.86% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share U-Neuron Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — U-Neuron Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — U-Neuron Biomedical